CORE LAB
TECHNOLOGIES

“-omics” technologies in combination with bioinformatics tools and biobanking are the prerequisites for the identification and validation of medical biomarkers. Metabolomics, genetics & genomics, an immunology platform and digital pathology are the core technologies used in CBmed.

In biomarker research metabolomics are used in the targeted and untargeted search for new biomarkers but also for the validation of biomarkers in different sets of samples. Genotyping technologies can be used to identify the underlying cause of a disease and result in the identification of new therapeutic targets.

  • Metabolomics

  • Genetics & Genomics

  • Immunology

  • Metabolomics

  • Genetics & Genomics

  • Immunology

  • Digital Pathology

  • Proteomics & In-vivo Imaging

  • MALDI-MS

Our in-house Core Labs

State-of-the-art flow cytometry is used to find activation markers for regulatory immune cells that are validated in different disease models. The same platform will be used to identify pattern recognition to validate biomarkers leading to fast new tools for early diagnosis of fungal infections.

The latest in digital pathology systems, capable of automated tissue recognition, simultaneous detection of multiple biomarkers and subsequent extraction & analysis of data, will enable in-situ immunophenotyping in the development of diagnostic and prognostic biomarkers for cancer and metabolic diseases.

The COMET Center CBmed is funded within COMET – Competence Centers for Excellent Technologies by the Federal Ministry of Transport, Innovation and Technology (BMVIT), the Federal Ministry for Digital and Economic Affairs (BMDW), Land Steiermark (Styrian Business Promotion Agency – SFG) and Land Wien (Vienna Business Agency – WAW). The COMET program is executed by the Austrian Research Promotion Agency (FFG).

CBmed GmbH Center for Biomarker Research in Medicine
Stiftingtalstrasse 5   8010 Graz   Austria   office@cbmed.at   +43 316 385 28801

PRESS CORNER     CONTACT     IMPRINT     PRIVACY

Font Resize
Contrast